2008
DOI: 10.1152/ajpheart.00856.2007
|View full text |Cite
|
Sign up to set email alerts
|

Hypoxic preconditioning increases survival and angiogenic potency of peripheral blood mononuclear cells via oxidative stress resistance

Abstract: Kubo M, Li TS, Suzuki R, Shirasawa B, Morikage N, Ohshima M, Qin SL, Hamano K. Hypoxic preconditioning increases survival and angiogenic potency of peripheral blood mononuclear cells via oxidative stress resistance.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
52
1

Year Published

2009
2009
2022
2022

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 48 publications
(57 citation statements)
references
References 35 publications
4
52
1
Order By: Relevance
“…Slides were then incubated with recombinant terminal deoxynucleotidyl transferase (GIBCO BRL, Life Technologies, Grand Island, NY, USA) and biotin 16-dUTP (Roche Diagnostics Corporation, Indianapolis, IN, USA) to label the nuclei of cells undergoing programmed cell death. 29 Colorimetric visualization, using avidin-HRP and DAB, was performed as described above.…”
Section: Histology and Immunohistochemistrymentioning
confidence: 99%
“…Slides were then incubated with recombinant terminal deoxynucleotidyl transferase (GIBCO BRL, Life Technologies, Grand Island, NY, USA) and biotin 16-dUTP (Roche Diagnostics Corporation, Indianapolis, IN, USA) to label the nuclei of cells undergoing programmed cell death. 29 Colorimetric visualization, using avidin-HRP and DAB, was performed as described above.…”
Section: Histology and Immunohistochemistrymentioning
confidence: 99%
“…Similarly, the cytoprotective effect of HPC was demonstrated in a number of in vivo studies using clinically relevant ischaemic models (Table 2). In these studies, ex vivo HPC rendered stem and progenitor cells more resilient to cell death when transplanted into the infarcted myocardium (He et al, 2009;Hu et al, 2008;Tang et al, 2009;Uemura et al, 2006), ischaemic limb (Akita et al, 2003;Kubo et al, 2008;Li et al, 2002;Rosova et al, 2008) or ischaemic brain (Theus et al, 2008), and this finding was significantly correlated with improved functional recovery of the ischaemic tissues. For instance, transplantation of hypoxic preconditioned mesenchymal stem cells (MSCs) into the ischaemic myocardium showed enhanced therapeutic benefits in terms of infarct size reduction, increased angiogenesis, improved ventricular function and less adverse cardiac remodelling .…”
Section: Survivalmentioning
confidence: 99%
“…Mechanistic evaluations of the cytoprotective effect of HPC in stem and progenitor cells have implicated the up-regulation of a diverse array of soluble survival proteins such as growth factor VEGF (Akita et al, 2003;Potier et al, 2007), anti-apoptotic proteins Bcl-2 and Bcl-xL (Francis & Wei, 2010;Hu et al, 2008;Theus et al, 2008;Wang et al, 2008a), antioxidants heme oxygenase-1, hexokinase-2, catalase and superoxide dismutase (Kubo et Theus et al, 2008) and NO (Uemura et al, 2006;Ii et al, 2005) as the contributing factors. Other potential cytokines and growth factors that have been suggested are basic fibroblast growth factor (bFGF) (Gnecchi et al, 2006), hepatocyte growth factor (HGF) (Gnecchi et al, 2006), IL-1 (Kubo et al 2008), IL-6 (Hung et al, 2007a) and thymosin 4 (Gnecchi et al, 2006), though more supporting evidence for these factors in mediating the pro-survival effect of HPC in the context of stem cell preconditioning are warranted. In addition, HPC has also been shown to activate several transcription factors and signal transduction cascades that are known to be Table 2.…”
Section: Survivalmentioning
confidence: 99%
See 1 more Smart Citation
“…To reduce invasiveness on collected transplanted cells, we used peripheral blood mononuclear cells (PBMNCs) instead of bone marrow cells and further examined the therapeutic effects of preconditioned PBMNCs on ischemic hindlimbs. Hypoxically pretreated PBMNCs improved microvessel density and limb blood flow in hindlimb ischemia models [12, 13]. …”
Section: Introductionmentioning
confidence: 99%